Literature DB >> 12270658

Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay.

Montserrat Puig1, Kathleen Mihalik, Mei-ying Yu, Stephen M Feinstone, Marian E Major.   

Abstract

The availability of molecular protocols for the detection and quantitation of very low numbers of hepatitis C virus (HCV) particles in biological samples is an issue of interest in both clinical and analytical fields of HCV research. A sensitive and reproducible assay is described for HCV RNA quantitation using the TaqMan PCR fluorogenic real-time detection system to establish the levels of HCV RNA in chimpanzee plasma. Our TaqMan PCR protocol and synthetic full length HCV RNA template show that the threshold of sensitivity for our TaqMan PCR is two copies per reaction. As few as 10 genome copies per reaction could be quantitated maintaining a linear range. The accuracy of the TaqMan PCR test was comparable to commercial bDNA and Amplicor tests. The RNA standards of the laboratory were tested in parallel with a World Health Organization (WHO) International Standard for HCV RNA obtaining ratios of 2.7+/-0.7 RNA copies per HCV international unit (IU). Our method using RNA extracted from chimpanzee samples had an estimated sensitivity of 200 RNA copies/ml of plasma (approximately eight copies/reaction or 74 WHO IU/ml). Serial plasma samples from HCV-infected chimpanzees were analyzed using this methodology to evaluate its applicability, and RNA profiles were observed consistent with the evolution of the pathology in each animal. The present study therefore illustrates the high reproducibility, sensitivity and reliability of our TaqMan methodology, providing a useful method for HCV research to consistently detect and quantify viral RNA throughout a range of concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270658     DOI: 10.1016/s0166-0934(02)00119-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  19 in total

1.  Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Authors:  Harel Dahari; Stephen M Feinstone; Marian E Major
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

2.  Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees.

Authors:  Iryna Zubkova; Hongying Duan; Frances Wells; Howard Mostowski; Esther Chang; Kathleen Pirollo; Kris Krawczynski; Robert Lanford; Marian Major
Journal:  Hepatology       Date:  2014-01-28       Impact factor: 17.425

3.  Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Authors:  Michelina Nascimbeni; Eishiro Mizukoshi; Markus Bosmann; Marian E Major; Kathleen Mihalik; Charles M Rice; Stephen M Feinstone; Barbara Rehermann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument.

Authors:  Jeffrey J Germer; W Scott Harmsen; Jayawant N Mandrekar; P Shawn Mitchell; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

5.  Detection of CK20mRNA in peripheral blood of pancreatic cancer and its clinical significance.

Authors:  Yun-Li Zhang; Jian-Guo Feng; Jian-Min Gou; Li-Xin Zhou; Ping Wang
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

6.  Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity.

Authors:  Javier Fernandez; Deborah Taylor; Duncan R Morhardt; Kathleen Mihalik; Montserrat Puig; Charles M Rice; Stephen M Feinstone; Marian E Major
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture.

Authors:  Erica Silberstein; Kathleen Mihalik; Laura Ulitzky; Ewan P Plant; Montserrat Puig; Sara Gagneten; Mei-ying W Yu; Neerja Kaushik-Basu; Stephen M Feinstone; Deborah R Taylor
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

8.  Neutralizing antibody response during acute and chronic hepatitis C virus infection.

Authors:  C Logvinoff; M E Major; D Oldach; S Heyward; A Talal; P Balfe; S M Feinstone; H Alter; C M Rice; J A McKeating
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

9.  Use of the MagNA pure LC automated nucleic acid extraction system followed by real-time reverse transcription-PCR for ultrasensitive quantitation of hepatitis C virus RNA.

Authors:  Linda Cook; Ka-Wing Ng; Arthur Bagabag; Lawrence Corey; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C.

Authors:  Tobias Manigold; Eui-Cheol Shin; Eishiro Mizukoshi; Kathleen Mihalik; Krishna K Murthy; Charles M Rice; Ciriaco A Piccirillo; Barbara Rehermann
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.